Beyond PSA testing for prostate cancer
Brooks, Doug, Olver, Ian N., and Esterman, Adrian J. (2018) Beyond PSA testing for prostate cancer. Medical Journal of Australia, 208 (10). pp. 424-426.
![[img]](https://researchonline.jcu.edu.au/style/images/fileicons/application_pdf.png) |
PDF (Published Version)
- Published Version
Restricted to Repository staff only |
DOI: 10.5694/mja18.00324
View at Publisher Website: https://doi.org/10.5694/mja18.00324
2
9
Abstract
Prostate cancer is now the most common cancer diagnosed in men in Australia,1 and Australia has one of the highest incidence rates of prostate cancer in the world, with an estimated age-standardised rate of 119.2 per 100 000 men.2 Before 1960, the primary diagnostic test for prostate cancer was the prostatic acid phosphatase test. This was eventually replaced in the 1980s by the prostate-specific antigen (PSA) test.
| Item ID: | 56395 |
|---|---|
| Item Type: | Article (Short Note) |
| ISSN: | 1326-5377 |
| Copyright Information: | Copyright 2018 AMPCo Pty Ltd. Produced with Elsevier B.V. All rights reserved. |
| Date Deposited: | 28 Nov 2018 09:21 |
| FoR Codes: | 11 MEDICAL AND HEALTH SCIENCES > 1112 Oncology and Carcinogenesis > 111202 Cancer Diagnosis @ 100% |
| SEO Codes: | 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920102 Cancer and Related Disorders @ 100% |
| Downloads: |
Total: 9 |
| More Statistics |
Actions (Repository Staff Only)
 |
Item Control Page |